Standard Biotools reported $127.07M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Danaher USD 870M 159M Jun/2026
Illumina USD 207M 73M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Nikon Corporation JPY 1.29B 161M Jun/2026
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Revvity USD 51.82M 11.1M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Sony JPY 342.16B 259.29B Jun/2026
Standard Biotools USD 127.07M 107.78M Mar/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Waters USD -136M 64M Jun/2026